Software provider ClearCourse has announced it has acquired medtech platform Blue Zinc for an undisclosed sum.
Shared exclusively with UKTN, Blue Zinc will join ClearCourse’s business services division.
Gerry Gualtieri, CEO, ClearCourse said: “Healthcare is one of the country’s most crucial sectors, and one in which we stand to see the most significant material benefits from tailored software and technology.”
Blue Zinc’s software allows for the management of patient referrals and clinics. The software is used in physiotherapy, musculoskeletal and mental healthcare.
Based in Belfast, earlier this year Blue Zinc acquired Collab IT, which was responsible for delivering its software in Australia.
The ClearCourse Blue Zinc acquisition is not the London-based company’s first.
London-based ClearCourse is a group of technology companies that backs software businesses aimed at small and medium enterprises.
Founded in 2018, ClearCourse opened a technology hub in Preston, Lancashire earlier this year.
“With ClearCourse’s support, we plan to scale and extend the services we provide to our existing clients, who play a vital role in the physical and mental wellbeing of patients worldwide, while bringing innovation to new areas of healthcare,” said Kyle Lunn, managing director, Blue Zinc.
Co-founders and managing directors Kyle Lunn and Ronnie Johnston will remain at Blue Zinc after the acquisition.
Other acquisitions this month include London-based Capdesk’s acquisition by California-based equity management company Carta.